New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and generalized ...

Patent filing follows acceptance into the NVIDIA Connect Program Proprietary software targets weather forecast-driven revenue ...

The Indian Patent Office has rejected AbbVie's patent application for its cancer drug Venetoclax, citing a lack of inventive ...

Propanc Biopharma, Inc. (Nasdaq: PPCB) is developing a novel approach to preventing cancer recurrence and metastasis by targeting and eradicating cancer stem cells through proenzyme activation. The ...

Cary Claiborne, President and Chief Executive Officer of Adial, commented, “As we continue to advance the AD04 program with planning for the next phase of our clinical program, the new patent ...

The Indian Patent Office rejected AbbVie’s patent application for cancer drug Venetoclax (Venclexta), a decision expected to ease the entry of lower-cost generics.

Too many entrepreneurs treat filing a patent as a milestone in itself—proof that their invention matters. But filing a patent too early, or without a clear business strategy, can create serious ...

CLAIM: A COVID-19 test patent application is dated 2020 but was actually filed in 2015. THE FACTS: The patent application, for a system to determine if someone has a viral infection such as COVID-19, ...

The US Court of Appeals for the Federal Circuit recently affirmed that, absent specification language supporting a narrower ...

Raluca Vasilescu of Cabinet M Oproiu finds that producing reliable, full patent applications remains a step too far for AI ...

“The [patent] statute confirms that IPRs should not be instituted based on patent applications that published after the priority date of the challenged patent [but] the PTAB has permitted IPRs to be ...

Canada’s Patent Term Adjustment (PTA) system came into force on January 1, 2025. PTA is only potentially available for ...